Rosuvastatin
Healthy Volunteers Sickle Cell Disease, Thalassemia
Novo Nordisk A/SSmall moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Healthy Volunteers Sickle Cell Disease, Thalassemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Etavopivat Novo Nordisk A/S | Phase 1 | CCC |
Metformin Novo Nordisk A/S | Phase 1 | CC |
MIDAZOLAM Novo Nordisk A/S | Phase 1 | CC |
PITAVASTATIN Novo Nordisk A/S | Phase 1 | CC |
Letrozole Novo Nordisk A/S | Phase 1 | CC |
DYNAMOS Novo Nordisk A/S | Phase 1 | CC |
Same molecule, other indications
Rosuvastatin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →